Log In
Print
BCIQ
Print
Print this Print this
 

Nucynta, Nucynta ER, tapentadol ER (CG5503/R331333)

  Manage Alerts
Collapse Summary General Information
Company Gruenenthal Group
DescriptionExtended-release formulation of mu opioid receptor (MOR) agonist and norepinephrine reuptake inhibitor
Molecular Target Mu opioid receptor (OPRM1) (MOR)
Mechanism of ActionMu opioid receptor agonist; Norepinephrine reuptake inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today